Pre-Clinical (Discovery and Development)
Find out how to fill up your pipeline and increase innovation. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in early discovery and preclinical research to exchange ideas on best practice and share case studies on innovation within the area.
AstraZeneca's Debut Biologic Respiratory Therapy Achieves Positive Results In Phase III trials
September 06 by Chanice HenryAstraZeneca plc (ADR) (NYSE:AZN) saw its first respiratory biomedicine receive primary and key secondary endpoints in the third phase of clinical trials. The therapy, Benralizumab, when combined...
Super-Vaccine Has Potential To Wipe-Out The World’s Most Deadly Bacterial Disease
August 23 by Pharma IQG-PN is a new vaccine which is a whole cell pneumococcal treatment that is inactivated by the presence of gamma irradiation. This biologic is said to have the capability to eliminate all of the 90 kno...
5 Reasons the Future of Calibration Will Be Governed By Integration
July 12 by Edward SimpsonA single error that occurs in a pharmaceutical lab adversely impacts the health of thousands of patients. This is exactly why calibration in a pharmaceutical facility is highly regulated for prec...
George Clinical Now Registered in South Korea.
June 09 by George Clinical RepresentativeGeorge Clinical – a leading contract research organisation (CRO)in the Asia-Pacific – is now a registered company in South Korea. George Clinical is headquartered in Sydney, Australia and has of...
Bioinformatics: Data Knowledge Management With Complex Datasets
May 31 by Pharma IQWith the growth of biologics showing no signs of stopping, bioinformatics continues to be a key driver when it comes to R&D development. Laboratories and their data s...
Six Steps To Achieving A Unified & Harmonised Lab
May 31 by Pharma IQA fully integrated laboratory can equip a pharma or biotech firm with better precision for decision-making as well as an acceleration in productivity.However, achieving end to end lab interoperab...
Emerging Trends within Cell & Gene Manufacturing
May 20 by Chanice HenryThe level of process efficiency behind today’s cell and gene therapies is said to rest at a low. The manufacturing behind them is mostly manual, due to the treatments mostly being within early de...
The Ascent of Precision Medicines
May 17 by Pharmaceuticals & Biotechnology EditorTraditionally the pharma industry has lent towards the view of a one-size fits all approach to the application of therapeutics. Now, eyes are set firmly on the notion of personalised medicine – therap...
Biospecimen Research Will Increase Success in Clinical Trials
April 28 by Kate Torchilin Ph.D.The efficient translation of discovery projects to clinical trials is necessary to improve productivity, decrease the risk of R&D projects, and ultimately deliver better medicines to patients fast...
Market Stakeholders Take Pit-Stop From The Immune Checkpoint Race
April 28 by Chanice HenryIn order to examine the therapy which has been labelled as a game changing addition to oncology, earlier this month industry stakeholders met to explore the evidenced potential of immune checkpoint mo...
Developing a Balanced Scorecard for a Core Laboratory
April 28 by Dr. Susan ShelbyThe balanced scorecard was first developed as a way for companies and organizations to more accurately measure their own performances. Today, these scorecards have evolved into vital tools for biophar...
Compound & Biobanking: Industry Forecasts
April 05 by Chanice Henry[inlinead]